Eric Lakin is an accomplished professional currently serving as Commercial Lead at both Palantir Technologies and Syntropy since July and November 2018, respectively. Previously, Eric held the position of Investor at GE Ventures from June 2017 to May 2018 and worked in Business Development at Caris Life Sciences for a brief period in early 2016. Eric's consulting experience at DeciBio spanned from September 2013 to February 2016. Educationally, Eric holds an MBA from Stanford University Graduate School of Business and a Bachelor of Arts degree in Classics and Pre-Med from UCLA.
This person is not in any teams
This person is not in any offices